TY - JOUR
T1 - Hepatocellular carcinoma risk factors and disease burden in a european cohort
T2 - A nested case-control study
AU - Trichopoulos, Dimitrios
AU - Bamia, Christina
AU - Lagiou, Pagona
AU - Fedirko, Veronika
AU - Trepo, Elisabeth
AU - Jenab, Mazda
AU - Pischon, Tobias
AU - Nöthlings, Ute
AU - Overved, Kim
AU - Tjønneland, Anne
AU - Outzen, Malene
AU - Clavel-Chapelon, Francoise
AU - Kaaks, Rudolf
AU - Lukanova, Annekatrin
AU - Boeing, Heiner
AU - Aleksandrova, Krasimira
AU - Benetou, Vassiliki
AU - Zylis, Dimosthenis
AU - Palli, Domenico
AU - Pala, Valeria
AU - Panico, Salvatore
AU - Tumino, Rosario
AU - Sacerdote, Carlotta
AU - Bueno-De-Mesquita, H. Bas
AU - Van Kranen, Henk J.
AU - Peeters, Petra H.M.
AU - Lund, Eiliv
AU - Quirós, J. Ramón
AU - González, Carlos A.
AU - Sanchez Perez, Maria Jose
AU - Navarro, Carmen
AU - Dorronsoro, Miren
AU - Barricarte, Aurelio
AU - Lindkvist, Björn
AU - Regnér, Sara
AU - Werner, Mårten
AU - Hallmans, Göran
AU - Khaw, Kay Tee
AU - Wareham, Nick
AU - Key, Timothy
AU - Romieu, Isabelle
AU - Chuang, Shu Chun
AU - Murphy, Neil
AU - Boffetta, Paolo
AU - Trichopoulou, Antonia
AU - Riboli, Elio
PY - 2011/11/16
Y1 - 2011/11/16
N2 - Background To date, no attempt has been made to systematically determine the apportionment of the hepatocellular carcinoma burden in Europe or North America among established risk factors. Methods Using data collected from 1992 to 2006, which included 4409809 person-years in the European Prospective Investigation into Cancer and nutrition (EPIC), we identified 125 case patients with hepatocellular carcinoma, of whom 115 were matched to 229 control subjects. We calculated odds ratios (ORs) for the association of documented risk factors for hepatocellular carcinoma with incidence of this disease and estimated their importance in this European cohort. Results Chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection (OR = 9.10, 95% confidence interval [CI] = 2.10 to 39.50 and OR = 13.36, 95% CI = 4.11 to 43.45, respectively), obesity (OR = 2.13, 95% CI = 1.06 to 4.29), former or current smoking (OR = 1.98, 95% CI = 0.90 to 4.39 and OR = 4.55, 95% CI = 1.90 to 10.91, respectively), and heavy alcohol intake (OR = 1.77, 95% CI = 0.73 to 4.27) were associated with hepatocellular carcinoma. Smoking contributed to almost half of all hepatocellular carcinomas (47.6%), whereas 13.2% and 20.9% were attributable to chronic HBV and HCV infection, respectively. Obesity and heavy alcohol intake contributed 16.1% and 10.2%, respectively. Almost two-thirds (65.7%, 95% CI = 50.6% to 79.3%) of hepatocellular carcinomas can be accounted for by exposure to at least one of these documented risk factors. Conclusions Smoking contributed to more hepatocellular carcinomas in this Europe-wide cohort than chronic HBV and HCV infections. Heavy alcohol consumption and obesity also contributed to sizeable fractions of this disease burden. These contributions may be underestimates because EPIC volunteers are likely to be more health conscious than the general population.
AB - Background To date, no attempt has been made to systematically determine the apportionment of the hepatocellular carcinoma burden in Europe or North America among established risk factors. Methods Using data collected from 1992 to 2006, which included 4409809 person-years in the European Prospective Investigation into Cancer and nutrition (EPIC), we identified 125 case patients with hepatocellular carcinoma, of whom 115 were matched to 229 control subjects. We calculated odds ratios (ORs) for the association of documented risk factors for hepatocellular carcinoma with incidence of this disease and estimated their importance in this European cohort. Results Chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection (OR = 9.10, 95% confidence interval [CI] = 2.10 to 39.50 and OR = 13.36, 95% CI = 4.11 to 43.45, respectively), obesity (OR = 2.13, 95% CI = 1.06 to 4.29), former or current smoking (OR = 1.98, 95% CI = 0.90 to 4.39 and OR = 4.55, 95% CI = 1.90 to 10.91, respectively), and heavy alcohol intake (OR = 1.77, 95% CI = 0.73 to 4.27) were associated with hepatocellular carcinoma. Smoking contributed to almost half of all hepatocellular carcinomas (47.6%), whereas 13.2% and 20.9% were attributable to chronic HBV and HCV infection, respectively. Obesity and heavy alcohol intake contributed 16.1% and 10.2%, respectively. Almost two-thirds (65.7%, 95% CI = 50.6% to 79.3%) of hepatocellular carcinomas can be accounted for by exposure to at least one of these documented risk factors. Conclusions Smoking contributed to more hepatocellular carcinomas in this Europe-wide cohort than chronic HBV and HCV infections. Heavy alcohol consumption and obesity also contributed to sizeable fractions of this disease burden. These contributions may be underestimates because EPIC volunteers are likely to be more health conscious than the general population.
UR - http://www.scopus.com/inward/record.url?scp=81855206498&partnerID=8YFLogxK
U2 - 10.1093/jnci/djr395
DO - 10.1093/jnci/djr395
M3 - Article
SN - 0027-8874
VL - 103
SP - 1686
EP - 1695
JO - Journal of the National Cancer Institute
JF - Journal of the National Cancer Institute
IS - 22
ER -